Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 4 of 4 entries
View as:

Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM

Phase: N/A Priority: Normal
NCT ID: NCT05836259 Org: User:
Start: 08/10/23 End: 08/31/32 Due: 08/31/33

Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT05112237 Org: User:
Start: 11/01/21 End: 06/30/28 Due: 06/30/29

Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Phase: N/A Priority: Normal
NCT ID: NCT06311708 Org: User:
Start: 01/31/23 End: 07/11/30 Due: 07/11/31

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

Phase: N/A Priority: Normal
NCT ID: NCT06228924 Org: User:
Start: 03/26/24 End: 10/01/29 Due: 10/01/30